Eli Lilly Corp. buy Wells Fargo & Company
Start price
24.01.24
/
50%
€584.00
Target price
24.01.25
€641.90
Performance (%)
25.67%
Price
30.04.24
€732.70
Summary
This prediction is currently active. The prediction currently has a performance of 25.67%. Dividends of €1.21 are taken into consideration when calculating the performance. This prediction currently runs until 24.01.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 5.213% | 5.213% |
| iShares Core DAX® | -1.370% | -3.231% |
| iShares Nasdaq 100 | 0.172% | -3.339% |
| iShares Nikkei 225® | -0.801% | -7.859% |
| iShares S&P 500 | -0.369% | -2.979% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Wells Fargo & Company from $650.00 to $700.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.50
06.02.24
06.02.24
€766.92
06.02.25
06.02.25
11.79%
30.04.24
30.04.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€535.00
09.10.23
09.10.23
€616.85
09.10.24
09.10.24
37.37%
30.04.24
30.04.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€471.80
08.08.23
08.08.23
€561.00
08.08.24
08.08.24
56.00%
30.04.24
30.04.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24